RC278
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RC278, covering 2025-11-26 to 2025-11-26. Get the full timeline:
Most recent: Clinical Trial Update: A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors [Phase 1, Phase 2]